Hotchkis & Wiley Capital Management Adds $56M in Elevance Health, Inc. ($ELV)

Key Points

  • Hotchkis & Wiley Capital Management changed its Elevance Health, Inc. ($ELV) stake by 6.8% last quarter, boosting to 2,191,563 shares worth $874.83 million.
  • Wall Street's consensus rating on $ELV is Buy and an average price target of $415.81.
  • $ELV last traded around $399.18.

Hotchkis & Wiley Capital Management increased its position in Elevance Health, Inc. ($ELV) by 6.8% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,191,563 shares of Elevance Health, Inc. after buying 140,413 shares during the quarter. Hotchkis & Wiley Capital Management's holdings in Elevance Health, Inc. were worth $874.83 million as of its most recent filing.

Elevance Health, Inc. ($ELV) Stock

Last price$399.18
Market cap$87.75B
P/E ratio17.12
Forward P/E13.82
PEG ratio1.48
Beta0.68
52-week low$273.71
52-week high$426.98
50-day MA$367.68
200-day MA$339.60
Current ratio1.48
Quick ratio1.33
Debt-to-equity0.72

Elevance Health, Inc. Earnings

EPS (ttm)$23.60
Revenue (ttm)$200.42B
Revenue growth2.6%
Net margin2.6%
Return on equity12.1%
Next earningsApr 22, 2026

Elevance Health, Inc. Dividend

Annual dividend$6.88
Dividend yield170.00%
Payout ratio29.0%
Ex-dividend dateJun 10, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$415.81
High target$498.00
Low target$331.00
Analysts covering21

About Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans
HeadquartersIndianapolis, IN
CEOMs. Gail Koziara Boudreaux
Employees96,129

See Also

This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.